Doctors must consider and review bylaws of hospital medical staff privileges when entertaining employment with a hospital or private practice
EULAR 2013: New RA Recommendations Address Combination Therapy Concerns
Guidelines give greater nod to use of combination conventional disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, leave monotherapy with methotrexate as acceptable first-line treatment
My Experience at the ACR Dallas Rheumatology Research Workshop
A second-year rheumatology fellow reflects on lectures and lessons learned at the event
Continued Congressional Lobbying by ACR Volunteers Needed to Repeal SGR
Ways you can advocate for legislation to replace the Medicare Sustainable Growth Rate formula
Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis
Disease Targeted Research Initiative may improve treatment, prevention of rheumatoid arthritis, other inflammatory diseases
New Insights into CPPD
Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease
Supreme Court Decision on Gene Patents Good News for Clinicians, Researchers
The recent U.S. Supreme Court decision that ruled human genes cannot be patented may provide greater access to genetic testing. (posted Sept. 24, 2013)
Lactoferricin’s Role in Preventing Disc Degeneration
The combination of bone-morphogenetic protein-7 (BMP7) and lactoferricin B (LfcinB) may be a useful treatment for disc degeneration. (posted Sept. 16, 2013)
Sensory Nerves May Be Key for Osteoporosis
Sensory nerves have an essential role in bone remodeling. In particular, semaphorin 3A (Sema3A) regulates bone remodeling by modulating sensory nerve development. (posted Sept. 9, 2013)
SGR Fix Finally on the Horizon?
By a 51–0 vote, the House Energy and Commerce Committee in July passed H.R. 2810, legislation that would repeal the Sustainable Growth Rate (SGR) formula. (posted Sept. 9, 2013)
- « Previous Page
- 1
- …
- 232
- 233
- 234
- 235
- 236
- …
- 303
- Next Page »